| Alcohol use in patients with chronic liver disease D Fuster, JH Samet New England Journal of Medicine 379 (13), 1251-1261, 2018 | 197 | 2018 |
| Time on antiretroviral therapy is a protective factor for liver fibrosis in HIV and hepatitis C virus (HCV) co‐infected patients C Tural, D Fuster, J Tor, I Ojanguren, G Sirera, A Ballesteros, JAJ Lasanta, ... Journal of viral hepatitis 10 (2), 118-125, 2003 | 137 | 2003 |
| Determinants of HIV progression and assessment of the optimal time to initiate highly active antiretroviral therapy: PISCIS Cohort (Spain) Á Jaén, A Esteve, JM Miró, C Tural, A Montoliu, E Ferrer, M Riera, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 47 (2), 212-220, 2008 | 105 | 2008 |
| Management of end stage liver disease (ESLD): what is the current role of orthotopic liver transplantation (OLT)? JM Miró, M Laguno, A Moreno, A Rimola, ... Journal of Hepatology 44, S140-S145, 2006 | 73 | 2006 |
| Early HCV dynamics on Peg-interferon and ribavirin in HIV/HCV co-infection: indications for the investigation of new treatment approaches ÁL Ballesteros, S Franco, D Fuster, R Planas, MÁ Martínez, L Acosta, ... Aids 18 (1), 59-66, 2004 | 70 | 2004 |
| Advanced liver fibrosis in HIV/HCV-coinfected patients on antiretroviral therapy D Fuster, R Planas, R Muga, AL Ballesteros, J Santos, J Tor, G Sirera, ... AIDS Research & Human Retroviruses 20 (12), 1293-1297, 2004 | 69 | 2004 |
| HIV-1 infected patients older than 50 years. PISCIS cohort study G Navarro, MM Nogueras, F Segura, J Casabona, JM Miro, J Murillas, ... Journal of infection 57 (1), 64-71, 2008 | 65 | 2008 |
| Liver transplantation in HIV/hepatitis co-infection. JM Miro, F Aguero, M Laguno, M Tuset, C Cervera, A Moreno, ... Journal of HIV Therapy 12 (1), 24-35, 2007 | 60 | 2007 |
| Prevalence and routine assessment of unhealthy alcohol use in hospitalized patients B Rosón, R Monte, R Gamallo, R Puerta, A Zapatero, J Fernández-Solá, ... European journal of internal medicine 21 (5), 458-464, 2010 | 59 | 2010 |
| Impact of medical comorbidity and risk of death in 680 patients with alcohol use disorders I Rivas, A Sanvisens, F Bolao, D Fuster, J Tor, R Pujol, M Torrens, ... Alcoholism: Clinical and Experimental Research 37, E221-E227, 2013 | 58 | 2013 |
| Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study S Serrano-Villar, J Martínez-Sanz, R Ron, A Talavera-Rodríguez, ... The lancet HIV 7 (8), e565-e573, 2020 | 53 | 2020 |
| Long-term mortality of patients with an alcohol-related Wernicke–Korsakoff syndrome A Sanvisens, P Zuluaga, D Fuster, I Rivas, J Tor, M Marcos, AJ Chamorro, ... Alcohol and Alcoholism 52 (4), 466-471, 2017 | 46 | 2017 |
| The model for end‐stage liver disease score is the best prognostic factor in human immunodeficiency virus 1–infected patients with end‐stage liver disease: a prospective cohort … J Murillas, A Rimola, M Laguno, E de Lazzari, J Rascón, F Agüero, ... Liver Transplantation 15 (9), 1133-1141, 2009 | 45 | 2009 |
| Alcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infections D Fuster, A Sanvisens, F Bolao, I Rivas, J Tor, R Muga World journal of hepatology 8 (31), 1295, 2016 | 42 | 2016 |
| Influence of the type of pegylated interferon on the onset of depressive and neuropsychiatric symptoms in HIV-HCV coinfected patients CR Fumaz, JA Munoz-Moreno, AL Ballesteros, R Paredes, MJ Ferrer, ... AIDS care 19 (1), 138-145, 2007 | 41 | 2007 |
| Interleukin-6 is associated with noninvasive markers of liver fibrosis in HIV-infected patients with alcohol problems D Fuster, JI Tsui, DM Cheng, EK Quinn, KA Armah, D Nunes, MS Freiberg, ... AIDS research and human retroviruses 29 (8), 1110-1116, 2013 | 40 | 2013 |
| Clinical-epidemiological characteristics and antiretroviral treatment trends in a cohort of HIV infected patients. The PISCIS Project A Jaén, J Casabona, A Esteve, JM Miró, C Tural, E Ferrer, M Riera, ... Medicina clinica 124 (14), 525-531, 2005 | 39 | 2005 |
| Inflammatory cytokines and mortality in a cohort of HIV-infected adults with alcohol problems D Fuster, DM Cheng, EK Quinn, KA Armah, R Saitz, MS Freiberg, ... Aids 28 (7), 1059-1064, 2014 | 37 | 2014 |
| Poor response to hepatitis C virus (HCV) therapy in HIV-and HCV-coinfected patients is not due to lower adherence to treatment R Solà, JA Galeras, S Montoliu, C Tural, L Force, S Torra, S Montull, ... AIDS Research & Human Retroviruses 22 (5), 393-400, 2006 | 37 | 2006 |
| Late presentation for HIV remains a major health issue in Spain: Results from a multicenter cohort study, 2004–2018 M Rava, L Domínguez-Domínguez, O Bisbal, LF López-Cortés, C Busca, ... PLoS One 16 (4), e0249864, 2021 | 34 | 2021 |
Bonaventura ClotetDirector irsiCaixa AIDS Research Institute在 irsicaixa.es 的电子邮件经过验证
